HC
Hongwei Cheng
I'm working on
4 months ago
Leader of a biotech company
About
Dr. Hongwei Cheng is the founder and the CEO of Pharmaplanter Technologies, a biotech company specialized in divers fields such as monoclonal antibody development, recombinant protein expression, lateral flow POC diagnostics, cell-based and animal-based modelling, and CRO services, among others.
Partnering listings
Learn more
pharmaplanter technologies inc
High-throughput screening platform for discovering acid and heat stable sweet proteins
A high-throughput cell-based screening platform for identifying novel sweet proteins as natural sugar alternatives. Uses FRET-based assays in HEK293 cells expressing hT1R2/T1R3 sweet taste receptors to screen plant prote...
Consulting serviceCompany
pharmaplanter technologies inc
Novel Therapeutic Target Discovery Platform for Neurodegenerative Diseases Using VEGF and Single-Cell Sequencing
A research platform combining cell-specific VEGF transgenic mouse models with single-cell sequencing to identify therapeutic targets for neurodegenerative diseases including ALS, Alzheimer's, Parkinson's, MS, Huntington'...
TechnologyConceptualCompany
pharmaplanter technologies inc
Rapid Lateral Flow Test for Bacterial Endotoxin Detection in Aqueous Solutions
A point-of-care lateral flow test (LFT) for rapid, cost-effective detection of bacterial endotoxins in aqueous solutions. Leveraging proven LFT technology and a dual-pathway development strategy, this diagnostic aims to ...
TechnologyConceptualCompany
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.
delivered to your inbox.
© 2026 Halo Cures, Inc.